
    
      The cost of performing a percutaneous coronary intervention is very variable since a large
      number of materials and human resources are considered, with the Stent cost being a
      fundamental factor; in developing countries, the cost this technology represents an important
      expense for the patient and the health system; which promotes the development of local
      technology to support the requirement of these devices.

      Ischemic heart disease together with cerebral vascular events is the main cause of, adding 15
      million deaths per year. Percutaneous revascularization is the gold standard choice in many
      of the variants of presentation of ischemic heart disease, the implantation of Stents is the
      most used method.

      Nowadays more and more countries start their own research and development of novel devices in
      order to reduce cost.

      Research question: Is the INC1 Bare Metal Stent safe and effective for the treatment of de
      novo coronary lesions in humans? Hypothesis: The INC1 Bare-metal Stent is safe and effective
      for the treatment of de novo coronary lesions in humans

      The INC1 Bare metal Stent is a 70uCoCr
    
  